Acorda Therapeutics (ACOR)

Acorda Therapeutics (ACOR) Financial Statements


Acorda Therapeutics Financial Overview

Acorda Therapeutics's market cap is currently ―. The company's EPS TTM is $-254.339; its P/E ratio is >-0.01; Acorda Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 37.98M$ 27.71M$ 29.68M$ 22.26M$ 31.47M
Gross Profit$ 32.39M$ 24.33M$ 26.61M$ 19.02M$ 39.46M
EBIT$ -247.66M$ -1.96M$ -3.57M$ -11.29M$ 27.40M
EBITDA$ -234.64M$ 10.84M$ 9.01M$ 1.09M$ 35.09M
Net Income Common Stockholders$ -217.76M$ -8.89M$ -9.38M$ -16.82M$ 19.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 29.98M$ 32.47M$ 26.10M$ 37.24M$ 44.42M
Total Assets$ 108.53M$ 366.34M$ 364.70M$ 372.52M$ 395.60M
Total Debt$ 190.90M$ 186.09M$ 181.50M$ 177.11M$ 172.92M
Net Debt$ 160.92M$ 153.62M$ 155.40M$ 139.86M$ 128.50M
Total Liabilities$ 266.48M$ 307.39M$ 296.83M$ 297.95M$ 301.97M
Stockholders Equity$ -157.96M$ 58.96M$ 67.87M$ 76.96M$ 93.62M
Cash Flow-
Free Cash Flow$ -3.06M$ 7.39M$ -11.56M$ -7.02M$ 9.19M
Operating Cash Flow$ -3.02M$ 7.61M$ -11.56M$ -7.02M$ 9.07M
Investing Cash Flow$ -44.00K$ -220.00K--$ 123.00K
Financing Cash Flow-----
Currency in USD

Acorda Therapeutics Earnings and Revenue History

Acorda Therapeutics Debt to Assets

Acorda Therapeutics Cash Flow

Acorda Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis